ADMA — Adma Biologics Inc

Price
$12.73
Change
-0.48 (-3.63%)
Open
$12.82
High
$13.20
Low
$12.53
Prev close
$13.21
Volume
4.6M

Adma Biologics Inc (ADMA) is listed on NASDAQ.

Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.

Searching for the Adma Biologics Inc share price, or whether to buy ADMA? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.

VAQO runs a statistical model over ADMA that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.

What ADMA is

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.…

Adma Biologics Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.

It trades on NASDAQ as a common stock.

ADMA size and valuation

At roughly $2.27B, ADMA is a mid-cap.

It earns 0.70 per share and trades at 14.5 times that.

Beta is 0.69: historically it has moved less than the market.

ADMA over the past year

Over the past year ADMA has traded between $7.21 and $20.46, and the current price sits at 42% of that range.

The 50-day average is $9.48 against a 200-day average of $11.66 — the shorter average sits below the longer one, usually read as a downtrend.

The published analyst target is $17.00, 33.5% above it. A target is an aggregate of opinions, not a measurement.

How Adma Biologics Inc (ADMA) is trading

Adma Biologics Inc (ADMA) is down 3.63% at $12.73 — a more volatile session than average.

The session ranged from $12.53 to $13.20 — 5.3% of the share price — and the current price sits at 30% of that range.

It opened at $12.82 against a previous close of $13.21 — an opening gap of -3.0%, which almost always comes from information released outside trading hours.

The day's range extended past the previous close ($13.21) on both sides.

Volume ran near 4.6M shares, about $59.2M of stock changing hands.

Traded alongside ADMA

Names traded alongside ADMA in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).

What VAQO's model says about ADMA

Two statistical models run over ADMA inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.

Key facts

  • Symbol: ADMA
  • Name: Adma Biologics Inc
  • Sector: HEALTHCARE
  • Industry: BIOTECHNOLOGY
  • Exchange: NASDAQ
  • Instrument: Stock

ADMA — frequently asked questions

What is the market cap of ADMA?

Adma Biologics Inc has a market capitalisation of roughly $2.27B.

What is the 52-week range for ADMA?

ADMA has traded between $7.21 and $20.46 over the past year, with the current price at 42% of that range.

What is the P/E ratio of ADMA?

ADMA trades at 14.5 times earnings, on earnings per share of 0.70.

How much does ADMA stock cost today?

Adma Biologics Inc (ADMA) trades at $12.73, a change of -3.63% in the latest session.

Is ADMA up or down today?

ADMA is down 3.63% in the latest session, at $12.73.

What is the daily trading range for ADMA?

ADMA traded between $12.53 and $13.20 in the latest session, and currently trades at $12.73.

What is the trading volume for ADMA?

ADMA traded roughly 4.6M shares in the latest session.

Which exchange is ADMA listed on?

ADMA is listed on NASDAQ, in the HEALTHCARE sector.

Should I buy ADMA stock?

VAQO gives no buy or sell recommendations and is not an investment adviser. The ADMA figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.

Others in HEALTHCARE

← All stocks on VAQO

Last updated: 2026-11-08